In four cases of acute myeloid leukaemia circulating polymorphs deficient in lactoferrin were detected: in one of these cases a similar percentage of polymorphs was lysozyme negative.
In a recent report from this laboratory an immunocytochemical technique was described for the demonstration of cytoplasmic lysozyme and lactoferrin in human white cells (Mason et al., 1975) . The first of these constituents is present in both myeloid and monocytic cells; the second is restricted to myeloid cells.
The present report is concerned with the distribution of these two substances in leucocytes from cases of myeloproliferative diseases. This study was designed, first, to investigate whether the demonstration of lysozyme and lactoferrin might aid the identification or classification of proliferating cells in these disorders; secondly, to study whether cases of monocytic leukaemia associated with marked increases in blood and urinary lysozyme are characterised by abnormally strong reactions for intracellular lysozyme: and, finally, to look for evidence of acquired deficiencies of intracellular lysozyme or lactoferrin in myeloid leukaemia and related diseases.
Patients and methods

PATIENTS
Samples were obtained from patients attending the Received for publication 28 October 1976 Radcliffe Infirmary, Oxford. The diagnosis of leukaemia and of other myeloproliferative disorders was based upon standard clinical and laboratory criteria. The number of patients in each diagnostic category is given in Table 1 . It should be noted that three cases of primary sideroblastic anaemia and paroxysmal nocturnal haemoglobinuria (PNH) have been included (under the category of chronic myeloproliferative disorders). Although not conventionally 
IMMUNOPEROXIDASE STAINING OF LYSOZYME AND LACTOFERRIN
The technique used for the demonstration of these constituents has been described previously and was applied without modification (Mason et al., 1975 (Mason et al., 1975) Sexauer et al. (1974) and Geary et al. (1975) in that they were elderly patients with a peripheral monocytosis, myelomonocytic bone marrow infiltration, and increased serum lysozyme levels.
The monocytoid cells from these patients showed weak staining reactions for lysozyme resembling normal monocytoid cells; as in the case of acute monocytic leukaemia (see section above), no monocytes stained as strongly for lysozyme as did myeloid cells. Monocytes from these patients were lactoferrin negative.
In two of these patients lactoferrin negative mature polymorphs were detected, associated in one case with a similar percentage of negative polymorphs in the preparation stained for lysozyme ( Furthermore, the reaction of Auer rods for lysozyme resembled that previously described for myeloperoxidase. This is in keeping with the fact that myeloperoxidase and lysozyme appear simultaneously in the course of normal myeloid maturation (at the promyelocyte stage), being both primary granule constituents (Spitznagel et al., 1974; Baggiolini et al., 1974; Bainton, 1975a Lactoferrin, as would be expected from its association with secondary granules in normal human myeloid cells Spitznagel et al., 1974; Bainton, 1975a) One possible advantage offered by these immunocytochemical techniques is that lactoferrin and lysozyme in blood or marrow smears are relatively stable on storage at room temperature (Mason et al., 1975) , so that immunoperoxidase staining may be of value when studying leukaemic samples retrospectively.
A further intention of this investigation was to see whether high levels of serum and urinary lysozyme encountered in cases of leukaemia showing monocytic differentiation would be paralleled by abnormally strong cytochemical reactions for intracellular lysozyme. In the five cases of monocytic leukaemia studied in the present survey, only weak reactions were observed, comparable in their intensity with the reactions of normal monocytes. The report by Perillie et al. (1968) that the intracellular lysozyme content of leukaemic monocytes is less than that of chronic myeloid leukaemic myelocytes and granulocytes accords with this finding. These results pose the paradox that leukaemia cells which are presumably liberating large amounts of lysozyme apparently contain relatively little of this material. One possible explanation is that the immunocytochemical technique is for some reason inefficient at detecting lysozyme in monocytes. A more probable explanation is that leukaemic monocytes liberate lysozyme rapidly after synthesising it so that no intracellular lysozyme pool accumulates. In contrast, myeloid cells, which store their complement of lysozyme in cytoplasmic granules and liberate it only at cell death or degranulation, react strongly for this protein.
Evidence of continuous liberation of lysozyme from cultured normal human monocytes, and for a greater intracellular content of this material in normal polymorphs than in normal monocytes, has been provided by Gordon et al. (1974) . Furthermore, Farhangi and Osserman (1974) , studying a case of monocytic leukaemia, were able to demonstrate, after incubation of bone marrow with labelled leucine, that newly synthesised lysozyme accumulated in the medium rather than in the leukaemic cells. Addi- tional evidence for the readiness with which lysozyme is liberated from monocytes is found in their ability to lyse adjacent organisms of Micrococcus lysodeikticus in the cytobacterial technique described by Syren and Raeste (1971) , and in the 'halo' Intracellular lysozyme and lactoferrin in myeloproliferative disorders effect noted in the present study when staining monocytes for lysozyme by the immunoperoxidase method (see results).
The observation by Asamer et al. (1971) of strong immunofluorescent staining for lysozyme in monocytes from three cases of monocytic leukaemia associated with heavy lysozymuria is in conflict with this concept. This discrepancy is conceivably explained by the presence of strongly staining myeloid cells among the monocytic population in their cases: the greater morphological cell detail visible in immunoperoxidase (as opposed to immunofluorescent) preparations is of value in correctly identifying monocytic and myelocytic cells.
Finally, this study sought evidence of acquired deficiencies of cellular lysozyme and/or lactoferrin in myeloproliferative disorders. The deficiency of neutrophil alkaline phosphatase, which is a feature of chronic myeloid leukaemia, suggested that additional deficiencies of neutrophil constituents might be detected in this disorder by immunoperoxidase staining. In particular, a depression or deficiency of lactoferrin reactivity might be expected on the grounds that alkaline phosphatase has been localised (in common with lactoferrin) to neutrophil secondary granules (Bainton, 1975a) .
In the present study no abnormalities of either lactoferrin or lysozyme reactivity were observed in chronic myeloid leukaemic neutrophils. It may be noted that recent work Spitznagel et al., 1974) has shown that alkaline phosphatase reactivity is in fact not associated with either primary or secondary human neutrophil granules but with a third subcellular fraction. Furthermore, electron microscopic examination of chronic myeloid leukaemic neutrophils reveals a normal complement of primary and secondary granules (Ullyot and Bainton, 1974) so that normal lactoferrin and lysozyme neutrophil reactivity in this disease is not an inconsistent finding. There has, however, been a recent report from Olofsson et al. (1975) (Odeberg et al., 1976) has recently reported a marked reduction in the quantity of lactoferrin extractable from neutrophils in cases of acute myeloid leukaemia, and a similar observation was made by Karle et al. (1974) for neutrophil lysozyme in this disease. Furthermore, Bainton (1975b) has reported deficiencies of both primary and secondary granules on ultrastructural examination of granulocytes from cases of acute myeloid leukaemia.
A close precedent to this leukaemia-associated deficiency of lysozyme and lactoferrin is provided by the deficiency of neutrophil myeloperoxidase which has been reported by a number of authors in cases of acute leukaemia (Hayhoe et al., 1967; Schmalzl et al., 1970; Davis et al., 1971; Catovsky et al., 1972) , presumably representing the production of abnormal polymorphs by the leukaemic myeloid clone. One point of difference from leukaemia-associated myeloperoxidase deficiency is found in the fact that lysozyme and lactoferrin deficiency was found in the present study in association with both myeloblastic leukaemia, whereas Catovsky et al. (1972) emphasised that neutrophil myeloperoxidase deficiency was rare in cases showing predominantly monocytic differentiation.
It remains to be determined whether deficiency of neutrophil lysozyme or lactoferrin can be incriminated as a cause of infectious complications in acute leukaemia. One obvious practical implication of these neutrophil deficiencies is that their demonstration may provide additional diagnostic information in the study of atypical myeloproliferative states such as 'preleukaemia' or refractory anaemia since it has already been demonstrated that myeloperoxidase deficiency can occur in these disorders (Catovsky et al., 1971; Bessis et al., 1969 
